Search results
Nektar Therapeutics (NKTR) Q2 Loss Narrows, Sales Miss
Zacks via Yahoo Finance· 10 months agoNektar Therapeutics NKTR reported a loss of 27 cents per share for the second quarter of 2023, which...
Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat
Zacks via Yahoo Finance· 3 months agoNektar Therapeutics NKTR reported an adjusted loss of 22 cents per share for the fourth quarter of...
Nektar's (NKTR) Q2 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoNektar (NKTR) reports dismal second-quarter 2022 results. The company's operating expenses increased...
Nektar Therapeutics (NKTR) Q1 Earnings & Revenues Beat
Zacks via Yahoo Finance· 1 year agoNektar Therapeutics NKTR reported a loss (excluding non-cash goodwill and other impairment charges)...
Nektar (NKTR), Cellular Biomedicine Join for Lung Cancer Studies
Zacks via Yahoo Finance· 8 months agoNektar NKTR announced a partnership with Cellular Biomedicine to develop its pipeline candidate,...
Here's Why You May Add Nektar (NKTR) Stock to Your Portfolio
Zacks via Yahoo Finance· 1 year agoNektar Therapeutics NKTR, which is focused on the development of treatments utilizing its PEGylation...
Nektar Therapeutics (NASDAQ:NKTR) Q1 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoNektar Therapeutics (NASDAQ:NKTR) Q1 2023 Earnings Call Transcript May 9, 2023 Operator: Good day...
Nektar Therapeutics (NASDAQ:NKTR) is largely controlled by institutional shareholders who own 70% of...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Significantly high institutional ownership implies Nektar Therapeutics' stock price is...
Nektar (NKTR) Starts New Restructuring Plan to Curb Cash Burn
Zacks via Yahoo Finance· 1 year agoThe new restructuring plan will allow Nektar (NKTR) to extend its cash runway into mid-2026. The...
Nektar Therapeutics (NKTR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks via Yahoo Finance· 2 years agoNektar (NKTR) doesn't possess the right combination of the two key ingredients for a likely earnings...